These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

500 related articles for article (PubMed ID: 6197100)

  • 1. Cerebrospinal fluid probenecid studies: a reinterpretation.
    Cowdry RW; Ebert MH; van Kammen DP; Post RM; Goodwin FK
    Biol Psychiatry; 1983 Nov; 18(11):1287-99. PubMed ID: 6197100
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine and serotonin metabolism in neuropsychiatrically disturbed children. CSF homovanillic acid and 5-hydroxyindoleacetic acid.
    Cohen DJ; Caparulo BK; Shaywitz BA; Bowers MB
    Arch Gen Psychiatry; 1977 May; 34(5):545-50. PubMed ID: 860891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Central metabolism of dopamine and serotonin. I. Determination of cerebrospinal fluid levels of HVA and 5-HIAA by the probenecid test (modified)].
    Carrieri P; Campanella G; Mandarini A; Orefice G; Buscaino GA
    Acta Neurol (Napoli); 1976; 31(5):558-64. PubMed ID: 1015382
    [No Abstract]   [Full Text] [Related]  

  • 4. Clinical application of the probenecid test for measurement of monoamine turnover in the CNS.
    Faull KF; Kraemer HC; Barchas JD; Berger PA
    Biol Psychiatry; 1981 Sep; 16(9):879-99. PubMed ID: 6170352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serotonin and dopamine disturbances in patients with unipolar depression and Parkinsonism.
    Mendlewicz J; Vanderheyden JE; Noel G
    Adv Exp Med Biol; 1981; 133():753-67. PubMed ID: 6172024
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probenecid: dosage, levels in plasma and cerebrospinal fluid (CSF) and influence upon CSF levels of homovanillic acid (HVA) and 5-hydroxyindoleacetic acid (5-HIAA) in the rabbit.
    Muizelaar JP; Oberink JI
    Psychopharmacologia; 1975 Sep; 43(3):223-7. PubMed ID: 1187954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations of monoamine metabolites and chlorpromazine in cerebrospinal fluid for prediction of therapeutic response in psychotic patients treated with neuroleptic drugs.
    Sedvall G
    Prog Biochem Pharmacol; 1980; 16():133-40. PubMed ID: 6160594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biogenic amines in autistic and atypical children. Cerebrospinal fluid measures of homovanillic acid and 5-hydroxyindoleacetic acid.
    Cohen DJ; Shaywitz BA; Johnson WT; Bowers M
    Arch Gen Psychiatry; 1974 Dec; 31(6):845-53. PubMed ID: 4441252
    [No Abstract]   [Full Text] [Related]  

  • 9. Intercorrelations among monoamine metabolite concentrations in human lumbar CSF are not due to a shared acid transport system.
    Jibson M; Faull KF; Csernansky JG
    Biol Psychiatry; 1990 Oct; 28(7):595-602. PubMed ID: 1699614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biogenic amine disturbances in cerebrospinal fluid in parkinsonism and unipolar depression: use of the probenecid method.
    Vanderheyden JE; Noel G; Mendlewicz J
    Neuropsychobiology; 1981; 7(3):137-51. PubMed ID: 6164951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between estimated premorbid adjustment and CSF homovanillic acid and 5-hydroxyindoleacetic acid levels.
    Leckman JF; Bowers MB; Sturges JS
    Am J Psychiatry; 1981 Apr; 138(4):472-7. PubMed ID: 6163366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF acid monoamine metabolities as a possible reflection of central MAO activity in chronic schizophrenia.
    Bowers MB
    Biol Psychiatry; 1976 Apr; 11(2):245-9. PubMed ID: 971448
    [No Abstract]   [Full Text] [Related]  

  • 13. Monoamine metabolites in human cerebrospinal fluid: indicators of neuronal activity?
    Scheinin M
    Med Biol; 1985; 63(1):1-17. PubMed ID: 2582215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Central metabolism of dopamine and serotonin. IV. Preliminary determinations of cerebrospinal fluid HVA and 5-HIAA in epileptic syndromes].
    Mandarini A; Buscaino GA; Rossi V; Orefice G; Carrieri P; Campanella G
    Acta Neurol (Napoli); 1976; 31(5):628-31. PubMed ID: 1015386
    [No Abstract]   [Full Text] [Related]  

  • 15. Monoamine metabolites in lumbar CSF: the question of their origin in relation to clinical studies.
    Garelis E; Young SN; Lal S; Sourkes TL
    Brain Res; 1974 Oct; 79(1):1-8. PubMed ID: 4279131
    [No Abstract]   [Full Text] [Related]  

  • 16. On the elimination of 5-hydroxyindoleacetic acid and homovanillic acid from cerebrospinal fluid.
    Andersson H; von Essen C; Roos BE
    Acta Pharmacol Toxicol (Copenh); 1973; 32(1):129-38. PubMed ID: 4741033
    [No Abstract]   [Full Text] [Related]  

  • 17. [Central metabolism of dopamine and serotonin. II. Significance of cerebrospinal fluid HVA and 5-HIAA changes in extrapyramidal and cerebellar syndromes].
    Buscaino GA; Mandarini A; Campanella G; Carrieri P; Orefice G
    Acta Neurol (Napoli); 1976; 31(5):565-70. PubMed ID: 138340
    [No Abstract]   [Full Text] [Related]  

  • 18. CSF monoamine metabolites in depression and schizophrenia.
    Berger PA; Faull KF; Kilkowski J; Anderson PJ; Kraemer H; Davis KL; Barchas JD
    Am J Psychiatry; 1980 Feb; 137(2):174-80. PubMed ID: 7352572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CSF monoamine metabolites in child and adult psychiatric patients. A developmental perspective.
    Leckman JF; Cohen DJ; Shaywitz BA; Caparulo BK; Heninger GR; Bowers MB
    Arch Gen Psychiatry; 1980 Jun; 37(6):677-81. PubMed ID: 6155891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid studies of monoamine metabolism in schizophrenia.
    van Kammen DP; Peters J; van Kammen WB
    Psychiatr Clin North Am; 1986 Mar; 9(1):81-97. PubMed ID: 2421272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.